共 50 条
Scaffold-Mediated Gene Delivery for Osteochondral Repair
被引:19
作者:
Madry, Henning
[1
]
Venkatesan, Jagadeesh Kumar
[1
]
Carballo-Pedrares, Natalia
[2
]
Rey-Rico, Ana
[2
]
Cucchiarini, Magali
[1
]
机构:
[1] Saarland Univ, Med Ctr, Ctr Expt Orthopaed, Kirrbergerstr Bldg 37, D-66421 Homburg, Germany
[2] Univ A Coruna, Ctr Invest Cient Avanzadas CICA, Cell Therapy & Regenerat Med Unit, ES-15071 La Coruna, Spain
关键词:
osteochondral repair;
gene therapy;
tissue engineering;
controlled delivery;
MESENCHYMAL STEM-CELLS;
ENDOTHELIAL GROWTH-FACTOR;
TISSUE-ENGINEERED CARTILAGE;
PLASMID DNA COMPLEXES;
ARTICULAR-CARTILAGE;
BONE REGENERATION;
IN-VIVO;
ACTIVATED MATRIX;
FIBRIN GEL;
TGF-BETA;
D O I:
10.3390/pharmaceutics12100930
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Osteochondral defects involve both the articular cartilage and the underlying subchondral bone. If left untreated, they may lead to osteoarthritis. Advanced biomaterial-guided delivery of gene vectors has recently emerged as an attractive therapeutic concept for osteochondral repair. The goal of this review is to provide an overview of the variety of biomaterials employed as nonviral or viral gene carriers for osteochondral repair approaches both in vitro and in vivo, including hydrogels, solid scaffolds, and hybrid materials. The data show that a site-specific delivery of therapeutic gene vectors in the context of acellular or cellular strategies allows for a spatial and temporal control of osteochondral neotissue composition in vitro. In vivo, implantation of acellular hydrogels loaded with nonviral or viral vectors has been reported to significantly improve osteochondral repair in translational defect models. These advances support the concept of scaffold-mediated gene delivery for osteochondral repair.
引用
收藏
页码:1 / 23
页数:22
相关论文
共 50 条